Robitussin Honey CF Max Non-Drowsy Adult recalled for microbial contamination
GSK Consumer Healthcare recalls Robitussin Honey CF Max Non-Drowsy Adult due to microbial contamination in non-sterile products distributed nationwide. Affected lot numbers carry specific expiration dates.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I drug recalls automatically qualify as a minimum score of 4 (Severe) per the rubric. This recall involves confirmed microbial contamination of a non-sterile product intended for consumption.
Plain-English summary
Robitussin Honey CF Max Non-Drowsy Adult, an over-the-counter cough and cold medication, is being recalled by the FDA. The product contains Acetaminophen 650 mg and Dextromethorphan HBr 20 mg and is available in 4 FL OZ (118 mL) and 8 FL OZ (237 mL) bottles distributed nationwide.
The FDA Class I recall was initiated due to microbial contamination of non-sterile products. The affected lots are Lot# T10810 (4 FL OZ size, expiring 10/31/2025) and Lot# T08730, T08731, T08732, T08733 (8 FL OZ size, expiring 05/31/2025), and Lot# T10808 (8 FL OZ size, expiring 09/30/2025).
Approximately 31,632 bottles of the 4 FL OZ size and 336,528 bottles of the 8 FL OZ size have been distributed. The product is manufactured by Haleon US Holdings LLC and distributed by GSK Consumer Healthcare, Warren, NJ.
Consumers who have purchased this product with the specified lot numbers should not use it. Those with questions or concerns should contact the manufacturer or their healthcare provider.
The recalled product
- Product
- Robitussin Honey CF Max Non-Drowsy Adult (Acetaminophen 650mg, Dextromethorphan HBr 20 mg), a) 4 FL OZ (118mL) and b) 8 FL OZ (237 mL) bottles, Distributed by: GSK Consumer Healthcare, Warren, NJ 07059
- Manufacturer
- Haleon US Holdings LLC
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- a) Lot#: T10810
- Exp 10/31/2025 b) Lot#: T08730
- T08731
- T08732
- T08733
- Exp 05/31/2025
- T10808
- Exp 09/30/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27